
David Guzo
Examiner (ID: 10142)
| Most Active Art Unit | 1636 |
| Art Unit(s) | 2899, 1805, 1636 |
| Total Applications | 1205 |
| Issued Applications | 693 |
| Pending Applications | 160 |
| Abandoned Applications | 352 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6918019
[patent_doc_number] => 20050095580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Method of determining adenovirus particle concentration'
[patent_app_type] => utility
[patent_app_number] => 10/505026
[patent_app_country] => US
[patent_app_date] => 2003-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5861
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095580.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505026
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505026 | Method of determining adenovirus particle concentration | Feb 13, 2003 | Issued |
Array
(
[id] => 6710870
[patent_doc_number] => 20030170619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Nucleic acid capable of promoting gene expression'
[patent_app_type] => new
[patent_app_number] => 10/361849
[patent_app_country] => US
[patent_app_date] => 2003-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9150
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170619.pdf
[firstpage_image] =>[orig_patent_app_number] => 10361849
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/361849 | Nucleic acid capable of promoting gene expression | Feb 10, 2003 | Abandoned |
Array
(
[id] => 7149873
[patent_doc_number] => 20040171108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Human excitatory amino acid transporter-2 gene promoter and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/360349
[patent_app_country] => US
[patent_app_date] => 2003-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11404
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171108.pdf
[firstpage_image] =>[orig_patent_app_number] => 10360349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/360349 | Human excitatory amino acid transporter-2 gene promoter and uses thereof | Feb 6, 2003 | Abandoned |
Array
(
[id] => 6701602
[patent_doc_number] => 20030224482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same'
[patent_app_type] => new
[patent_app_number] => 10/360081
[patent_app_country] => US
[patent_app_date] => 2003-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 15582
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224482.pdf
[firstpage_image] =>[orig_patent_app_number] => 10360081
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/360081 | Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same | Feb 5, 2003 | Abandoned |
Array
(
[id] => 7355894
[patent_doc_number] => 20040013653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins'
[patent_app_type] => new
[patent_app_number] => 10/352839
[patent_app_country] => US
[patent_app_date] => 2003-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11050
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20040013653.pdf
[firstpage_image] =>[orig_patent_app_number] => 10352839
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/352839 | Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins | Jan 27, 2003 | Issued |
Array
(
[id] => 6846859
[patent_doc_number] => 20030166026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Identification of specific biomarkers for breast cancer cells'
[patent_app_type] => new
[patent_app_number] => 10/339782
[patent_app_country] => US
[patent_app_date] => 2003-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 34040
[patent_no_of_claims] => 92
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166026.pdf
[firstpage_image] =>[orig_patent_app_number] => 10339782
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/339782 | Identification of specific biomarkers for breast cancer cells | Jan 7, 2003 | Abandoned |
Array
(
[id] => 6829682
[patent_doc_number] => 20030180740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Differential expression screening method'
[patent_app_type] => new
[patent_app_number] => 10/204724
[patent_app_country] => US
[patent_app_date] => 2003-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 30846
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180740.pdf
[firstpage_image] =>[orig_patent_app_number] => 10204724
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/204724 | Differential expression screening method | Jan 1, 2003 | Abandoned |
Array
(
[id] => 6707777
[patent_doc_number] => 20030154511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Plant retroviral polynucleotides and methods for use thereof'
[patent_app_type] => new
[patent_app_number] => 10/334703
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 22932
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20030154511.pdf
[firstpage_image] =>[orig_patent_app_number] => 10334703
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/334703 | Plant retroviral polynucleotides and methods for use thereof | Dec 19, 2002 | Abandoned |
Array
(
[id] => 985395
[patent_doc_number] => 06924123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-02
[patent_title] => 'Lentiviral LTR-deleted vector'
[patent_app_type] => utility
[patent_app_number] => 10/324616
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 9667
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/924/06924123.pdf
[firstpage_image] =>[orig_patent_app_number] => 10324616
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/324616 | Lentiviral LTR-deleted vector | Dec 19, 2002 | Issued |
| 10/069623 | Use of rafp to inhibit or prevent apoptosis | Dec 15, 2002 | Abandoned |
Array
(
[id] => 6740321
[patent_doc_number] => 20030157690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Fusion protein delivery system and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/306885
[patent_app_country] => US
[patent_app_date] => 2002-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 12212
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157690.pdf
[firstpage_image] =>[orig_patent_app_number] => 10306885
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/306885 | Fusion protein delivery system and uses thereof | Nov 26, 2002 | Abandoned |
Array
(
[id] => 1173344
[patent_doc_number] => 06746690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-08
[patent_title] => 'Process for producing composite preparation containing nucleic acid'
[patent_app_type] => B2
[patent_app_number] => 10/294865
[patent_app_country] => US
[patent_app_date] => 2002-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 5586
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/746/06746690.pdf
[firstpage_image] =>[orig_patent_app_number] => 10294865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/294865 | Process for producing composite preparation containing nucleic acid | Nov 13, 2002 | Issued |
Array
(
[id] => 7461769
[patent_doc_number] => 20040197895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Packaging lines for generation of high titers or recombinant aav vectors'
[patent_app_type] => new
[patent_app_number] => 10/415834
[patent_app_country] => US
[patent_app_date] => 2003-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 20035
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20040197895.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415834
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415834 | Production of adeno-associated virus in insect cells | Nov 7, 2002 | Issued |
Array
(
[id] => 1040482
[patent_doc_number] => 06869780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-22
[patent_title] => 'Nodavirus-like DNA expression vector and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/230730
[patent_app_country] => US
[patent_app_date] => 2002-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10421
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/869/06869780.pdf
[firstpage_image] =>[orig_patent_app_number] => 10230730
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/230730 | Nodavirus-like DNA expression vector and uses therefor | Nov 3, 2002 | Issued |
Array
(
[id] => 6669397
[patent_doc_number] => 20030114381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Method of treating sensorineural hearing loss'
[patent_app_type] => new
[patent_app_number] => 10/274180
[patent_app_country] => US
[patent_app_date] => 2002-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8466
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10274180
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/274180 | Method of treating sensorineural hearing loss | Oct 17, 2002 | Abandoned |
Array
(
[id] => 7212319
[patent_doc_number] => 20050054105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Adenoviral vector system'
[patent_app_type] => utility
[patent_app_number] => 10/491936
[patent_app_country] => US
[patent_app_date] => 2002-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7919
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054105.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491936
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491936 | Adenoviral vector system | Oct 3, 2002 | Abandoned |
Array
(
[id] => 6869456
[patent_doc_number] => 20030082145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Adeno-associated virus materials and methods'
[patent_app_type] => new
[patent_app_number] => 10/263127
[patent_app_country] => US
[patent_app_date] => 2002-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7089
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082145.pdf
[firstpage_image] =>[orig_patent_app_number] => 10263127
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/263127 | Adeno-associated virus materials and methods | Oct 1, 2002 | Abandoned |
Array
(
[id] => 445698
[patent_doc_number] => 07252991
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-07
[patent_title] => 'Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells'
[patent_app_type] => utility
[patent_app_number] => 10/260516
[patent_app_country] => US
[patent_app_date] => 2002-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 19
[patent_no_of_words] => 25796
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/252/07252991.pdf
[firstpage_image] =>[orig_patent_app_number] => 10260516
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/260516 | Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells | Sep 30, 2002 | Issued |
Array
(
[id] => 6787715
[patent_doc_number] => 20030138954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Methods and compositions relating to restricted expression lentiviral vectors and their applications'
[patent_app_type] => new
[patent_app_number] => 10/261078
[patent_app_country] => US
[patent_app_date] => 2002-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 26736
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20030138954.pdf
[firstpage_image] =>[orig_patent_app_number] => 10261078
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/261078 | Methods and compositions relating to restricted expression lentiviral vectors and their applications | Sep 29, 2002 | Issued |
Array
(
[id] => 7122431
[patent_doc_number] => 20050014260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Fusion protein delivery system and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/245475
[patent_app_country] => US
[patent_app_date] => 2002-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 14136
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014260.pdf
[firstpage_image] =>[orig_patent_app_number] => 10245475
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/245475 | Fusion protein delivery system and uses thereof | Sep 16, 2002 | Issued |